Tamiflu (oseltamivir phosphate) Information
FDA approved Tamiflu (oseltamivir phosphate), an oral anti-viral drug for the treatment of
uncomplicated influenza in patients one year and older whose flu symptoms have not lasted
more than two days. This product is approved to treat Type A and B influenza; however, the majority of patients included in the studies were infected with type A, the most common in the U.S. Efficacy of Tamiflu in the
treatment of influenza in subjects with chronic cardiac disease and/or respiratory disease
has not been established.
Tamiflu is also approved for the prevention of influenza in adults and children aged one year and older. Efficacy of Tamiflu for the prevention of influenza has not been established in immunocompromised patients.
Back to Drug Information
Date created: October 10, 1999, Last updated: April 7, 2008